Literature DB >> 29685084

Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.

Katherine A Lees1, Nicole M Tombers1, Michael J Link1,2, Colin L Driscoll1,2, Brian A Neff1, Jamie J Van Gompel1,2, John I Lane3, Christine M Lohse4, Matthew L Carlson1,2.   

Abstract

Objective (1) Assess 3-dimensional volumetric growth of untreated sporadic vestibular schwannomas (VSs) in a large cohort of patients treated with conservative observation. (2) Compare volumetric and conventional linear diameter measurements for detecting tumor growth. Study Design Case series with chart review. Setting Tertiary skull base referral center. Subjects and Methods Patients with sporadic VS who elected initial conservative treatment with at least 2 serial magnetic resonance imaging (MRI) scans were included. Tumor volume was determined with 3-dimensional segmentation of MRI sequences. The volumetric threshold for tumor growth was an increase ≥20% from baseline tumor volume. Tumor size based on linear diameter was assessed with the 1995 American Academy of Otolaryngology-Head and Neck Surgery Foundation guidelines for VS outcome reporting, with growth defined as an increase ≥2 mm. Results A total of 361 patients were included with a median radiologic follow-up of 4.1 years (interquartile range [IQR], 2.5-6.8). At diagnosis, 232 VSs (64%) were purely intracanalicular, and 129 (36%) extended into the cerebellopontine angle. The median baseline tumor volume was 0.161 cm3 (IQR, 0.054-0.418). Overall, 69% of tumors demonstrated volumetric growth at a median of 1.1 years (IQR, 0.6-2.1) after initial MRI. In contrast, based on linear measurement assessment, 48% of tumors demonstrated growth at a median of 1.8 years (IQR, 0.8-3.1) from first MRI scan. Disequilibrium, facial hypoesthesia, aural fullness, initial tumor size, and nonincidental diagnosis were associated with tumor growth. Conclusion Three-dimensional volumetric assessment of VS provides a more sensitive measure of tumor growth when compared with linear diameter assessment. Through volumetric analysis, the current study revealed that a significant proportion of VSs demonstrate growth during observation.

Entities:  

Keywords:  acoustic neuroma; natural history; neurotology; skull base; vestibular schwannoma; volumetric

Mesh:

Year:  2018        PMID: 29685084     DOI: 10.1177/0194599818770413

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  16 in total

1.  The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

2.  Vestibular Schwannoma Tumor Size and Growth Rate Predict Response with Gamma Knife Stereotactic Radiosurgery.

Authors:  Daniel E Killeen; Anthony M Tolisano; Brandon Isaacson; J Walter Kutz; Samuel Barnett; Zabi Wardak; Jacob B Hunter
Journal:  J Neurol Surg B Skull Base       Date:  2020-10-05

Review 3.  Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma Microenvironment.

Authors:  Cathal J Hannan; Daniel Lewis; Claire O'Leary; Carmine A Donofrio; Dafydd G Evans; Emma Stapleton; Simon R Freeman; Simon K Lloyd; Scott A Rutherford; Charlotte Hammerbeck-Ward; David Brough; Stuart M Allan; David Coope; Andrew T King; Omar N Pathmanaban
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-10

4.  Fully Automated 3D Vestibular Schwannoma Segmentation with and without Gadolinium-based Contrast Material: A Multicenter, Multivendor Study.

Authors:  Olaf M Neve; Yunjie Chen; Qian Tao; Stephan R Romeijn; Nick P de Boer; Willem Grootjans; Mark C Kruit; Boudewijn P F Lelieveldt; Jeroen C Jansen; Erik F Hensen; Berit M Verbist; Marius Staring
Journal:  Radiol Artif Intell       Date:  2022-06-22

5.  Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients.

Authors:  John P Marinelli; Zane Schnurman; Daniel E Killeen; Ashley M Nassiri; Jacob B Hunter; Katherine A Lees; Christine M Lohse; J Thomas Roland; John G Golfinos; Douglas Kondziolka; Michael J Link; Matthew L Carlson
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

Review 6.  Assessing the long-term safety and efficacy of gamma knife and linear accelerator radiosurgery for vestibular schwannoma: A systematic review and meta-analysis.

Authors:  Sergio W Guadix; Alice J Tao; Anjile An; Michelle Demetres; Umberto Tosi; Swathi Chidambaram; Jonathan P S Knisely; Rohan Ramakrishna; Susan C Pannullo
Journal:  Neurooncol Pract       Date:  2021-08-13

7.  The Effect of Prescription Isodose Variation on Tumor Control and Toxicities in Stereotactic Radiosurgery for Sporadic Vestibular Schwannoma: Propensity Score-Matched Case-Control Study.

Authors:  Achiraya Teyateeti; Christopher S Graffeo; Avital Perry; Eric J Tryggestad; Paul D Brown; Bruce E Pollock; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

8.  Manual segmentation versus semi-automated segmentation for quantifying vestibular schwannoma volume on MRI.

Authors:  Hari McGrath; Peichao Li; Reuben Dorent; Robert Bradford; Shakeel Saeed; Sotirios Bisdas; Sebastien Ourselin; Jonathan Shapey; Tom Vercauteren
Journal:  Int J Comput Assist Radiol Surg       Date:  2020-07-16       Impact factor: 2.924

9.  Initial Observation among Patients with Vestibular Schwannoma.

Authors:  Henry Ruiz-Garcia; Jennifer Peterson; Janet Leon; Timothy Malouff; Laura Vallow; Larry Lundy; Kaisorn L Chaichana; Prasanna Vibhute; Daniel M Trifiletti
Journal:  J Neurol Surg B Skull Base       Date:  2020-01-24

Review 10.  Outcomes of stereotactic radiosurgery for large vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Umberto Tosi; Miguel E Tusa Lavieri; Anjile An; Omri Maayan; Sergio W Guadix; Antonio P DeRosa; Paul J Christos; Susan Pannullo; Philip E Stieg; Andrew Brandmaier; Jonathan P S Knisely; Rohan Ramakrishna
Journal:  Neurooncol Pract       Date:  2021-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.